JHX Q4 earnings — Revenue +45% YoY · EPS -83% YoY · EBIT +116% YoY

The Print

James Hardie Industries plc (JHX) recorded 44.5% year-over-year revenue growth to $1.40 billion in its Q4 2026 fiscal quarter, per SEC 8-K Item 2.02 filed on 2026-05-19 at 16:32:38 (filing link: https://www.sec.gov/Archives/edgar/data/1159152/000162828026036497/jhx-20260519.htm). Diluted EPS fell 83.3% YoY to $0.0166 from $0.0993, while EBIT rose 115.9% YoY to $75 million from $35 million in the year-ago quarter.

Operating Leverage

EBIT growth outpaced top-line expansion by 71.4 percentage points, confirming meaningful operating margin expansion. Calculated from reported figures, Q4 2026 EBIT margin hit ~5.4% ($75M / $1.40B), up from ~3.6% in the year-ago quarter, a 1.8 percentage point improvement. This strong core operating performance runs counter to the sharp YoY diluted EPS decline, which likely stems from one-time non-operating charges or increased non-core expenses not tied to day-to-day operations.

Forward Outlook

JHX issued full-year 2027 fiscal guidance in Exhibit 99.1 of the same 8-K filing. The provided dataset does not include specific quantitative guidance targets, so no sequential or year-over-year comparisons to the just-reported quarter or prior fiscal periods can be made using the disclosed materials.

Cross-Reference to Prior Market Signals

Analyst rating trends show a modest shift in coverage ahead of the earnings release: as of May 1, 2026, JHX had 1 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell ratings, down from 1 Strong Buy, 7 Buy, 1 Hold, 0 Sell, and 0 Strong Sell on April 1, 2026. This indicates one analyst upgraded their rating from Hold to Buy in the four weeks prior to earnings. Separately, all March 17, 2026 through April 7, 2026 Form 4 insider transactions reflect zero share purchases or sales, with no material insider activity reported. Institutional ownership data from 2025-12-31 13F filings shows 297 institutional holders (a net increase of 3) holding 38.9% of JHX’s float, with 71 new positions, 157 increased positions, 94 reduced positions, and 65 fully closed positions.

Unreported Data Points

This earnings release does not provide three key additional metrics: 1) Segment-specific revenue and EBIT breakdowns for Q4 2026 and full-year 2026, which would typically be included in the accompanying 10-Q filing; 2) Balance sheet metrics including quarterly cash flow, total debt, and capital expenditure spending; 3) Specific quantitative financial targets for FY27 guidance, as the provided 8-K filing did not disclose disclosed ranges for the full fiscal year.